Analysis of the responses of coricosteroid in the patients with respiratory deseases and autoimmunologic inflammatory diseases

Analysis of the responses of coricosteroid in the patients with allergic respiratory deseases and autoimmunologic inflammatory diseases - CS responder in Allergic Respir and Autoimmune

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220251

Enrollment

500

Registered

2016-06-13

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma and autoimmunological disease

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of administration / Site of application: Dose per administration: Dosing frequency / Freq

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patinets with allergic respiratory disease, or rheumatic diseases, who have been already diagnosed and administered with corticosteroids

Exclusion criteria

Exclusion criteria: smokers and tumor-bearing patients

Design outcomes

Primary

Measure	Time frame
amount of use of steroids to control diseases activities	—

Secondary

Measure	Time frame
pulmonary functiion, activities of diseases	—

Contacts

Public ContactYutaka Nakamura

Iwate Medical University School of Medicine

ICB75097@nifty.com+81-19-651-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026